ONGENTYS
Peakopicapone
NDAORALCAPSULE
Approved
Apr 2020
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
15
Mechanism of Action
Catechol O-Methyltransferase Inhibitors
Pharmacologic Class:
Catechol-O-Methyltransferase Inhibitor
Clinical Trials (5)
eArly levoDopa With Opicapone in Parkinson's paTients wIth motOr fluctuatioNs.
Started Nov 2021
OpicApone Sleep dISorder
Started Jun 2021
Early ParkinSon wIth L-DOPA/DDCI and OpicapoNe (EPSILON Study)
Started May 2021
OpiCapone Effect on Motor Fluctuations and pAiN
Started Feb 2021
Safety and Effectiveness of Opicapone Plus Standard of Care in Elderly Patients With Parkinson's Disease
Started Apr 2020
Loss of Exclusivity
LOE Date
Dec 12, 2032
82 months away
Patent Expiry
Dec 12, 2032